Targeting of S100A4 by a specific antibody was further demonstrated to abolish endothelial cell migration, tumor growth and angiogenesis in mouse xenografts models of M21 melanoma and MIA PaCa-2 pancreatic cancers [181]. This evidence concerns the gene S100A4 and neoplasm.